Mimedx (MDXG) Other Operating Expenses (2017 - 2019)

Mimedx (MDXG) reported Other Operating Expenses of $2.3 million for Q4 2019, up 841.35% on a YoY basis from $245712.0 in Q4 2018, and up 202.57% sequentially from -$2.3 million in Q3 2019.

Mimedx (MDXG) Other Operating Expenses (2017 - 2019) Analysis & Trends

Mimedx (MDXG) has 3 years of Other Operating Expenses data on file, last reported at $2.3 million in Q4 2019.

  • For the quarter ending Q4 2019, Other Operating Expenses rose 841.35% year-over-year to $2.3 million; the trailing twelve-month figure through Sep 2020 stood at $2.3 million (up 190.11% YoY), and the FY2020 full-year result was -$8.2 million, changed N/A from the prior year.
  • Other Operating Expenses grew to $2.3 million in Q4 2019, from -$2.3 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $2.3 million in Q4 2019 to a low of -$2.3 million in Q3 2019.
  • A 3-year average of -$240600.0 and a median of -$312000.0 in 2018 frame the typical range for Other Operating Expenses.
  • Peak annual rise in Other Operating Expenses reached 841.35% in 2019, while the deepest fall reached 2377.78% in 2019.
  • Tracing MDXG's Other Operating Expenses over 3 years: stood at -$1.0 million in 2017, then jumped by 70.23% to -$312000.0 in 2018, then jumped by 841.35% to $2.3 million in 2019.
  • Business Quant data shows MDXG's Other Operating Expenses at $2.3 million in Q4 2019, -$2.3 million in Q3 2019, and -$312000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mimedx 615.09 Mn 455.31 Mn 41.62 Mn

Historic Data

Download Data
DateValue
Dec 31, 2019 2.31 Mn
Sep 30, 2019 -2.26 Mn
Dec 31, 2018 -312,000.00
Sep 30, 2018 99,000.00
Sep 30, 2017 -1.05 Mn